Systematic ReviewModerate Evidence2014

39 Studies Later, the Evidence That Cannabis Helps You Sleep Is Weaker Than You Think

The effects of cannabinoid administration on sleep: a systematic review of human studies

Gates, Peter J.; Albertella, Lucy; Copeland, Jan·Sleep Medicine Reviews·PubMed

Bottom Line

The first systematic review of cannabinoid effects on human sleep found mixed results across 39 studies — consumer confidence in cannabis as a sleep aid had vastly outpaced the evidence.

Why It Matters

Cannabis is widely used as a self-managed sleep aid. This review asked what controlled human studies actually measured when cannabinoids were given and sleep was quantified. In 2014, it set a baseline for how uncertain the evidence was, at a time when policy and consumer adoption were moving faster than the science.

The Backstory

Here's something that should bother you: an estimated 48% of cannabis users say they use it to help them sleep. It's one of the top three reasons people give for using cannabis. Walk into any dispensary and you'll find entire product lines — indica strains, CBN gummies, THC tinctures — marketed as sleep aids. The consumer confidence is enormous.

So when Peter Gates and his colleagues at the University of New South Wales decided to round up every controlled human study that actually gave someone a cannabinoid and then measured what happened to their sleep, you'd expect the evidence to be solid. Overwhelming, even. Dozens of studies confirming what millions of people report every night.

That's not what they found.

The Review

Published in Sleep Medicine Reviews in 2014 — just as cannabis legalization was accelerating in the United States and self-medication was becoming mainstream — Gates' team conducted the first comprehensive systematic review focused specifically on cannabinoid administration and sleep in humans.

They searched eight electronic databases for every study that met two criteria: a cannabinoid was administered, and at least one quantitative sleep outcome was measured. They excluded reviews, opinion pieces, case studies with fewer than seven participants, and non-English papers. What remained were 39 publications spanning decades of research — from early THC studies in the 1970s through synthetic cannabinoid trials in the 2000s.

39

human studies that administered a cannabinoid and measured sleep quantitatively — the entire controlled evidence base through 2014.

For context, there are more than 10,000 published studies mentioning cannabis. Only 39 met the basic bar of: we gave someone a cannabinoid and measured what happened to their sleep.

Gates et al. (2014), Sleep Medicine Reviews

The finding that defined the review: the results didn't converge. Not into a clear benefit. Not into a clear harm. Not into anything clean enough to build clinical guidance around.

What 39 Studies Actually Showed

The review organized findings by sleep parameter. Here's what emerged across the evidence base:

The pattern across every parameter was the same: some studies said yes, some said no, methodological differences made comparison nearly impossible, and the overall signal was too weak to support firm conclusions.

The Paradox: You Feel Like You're Sleeping Better

This is the part that matters most and the part that's hardest to hear.

Myth vs. Reality

Myth

Cannabis is a reliable sleep aid — it helps you fall asleep faster, sleep deeper, and wake more rested.

Reality

Controlled studies show inconsistent effects on every measurable sleep parameter. The most consistent finding is a subjective sense of improved sleep that is frequently not confirmed by objective sleep measurement. Cannabis may make you feel like you slept better without actually improving — and in some cases while degrading — the quality of your sleep.

The Evidence

Gates' review of 39 human studies found mixed results across sleep onset latency, total sleep time, slow-wave sleep, and REM sleep. Self-report measures and polysomnography results often diverged, with users reporting improvement while objective instruments detected no change or worsening in sleep architecture.

Gates et al. (2014), Sleep Medicine Reviews

The subjective-objective disconnect is one of the most important findings in the cannabis-sleep literature, and it runs deeper than simple placebo effect. THC is psychoactive. It alters consciousness, reduces anxiety, and produces sedation — all of which make you feel like you're falling asleep more easily. But feeling sedated and achieving restorative sleep are not the same thing. Alcohol produces a similar disconnect: people fall asleep faster after drinking but sleep worse by every objective measure.

This doesn't mean every cannabis user's sleep experience is an illusion. Some people with specific conditions — anxiety-driven insomnia, chronic pain that disrupts sleep, PTSD nightmares — may genuinely sleep better with cannabinoids because the drug addresses the underlying cause of their sleep disruption. But the idea that cannabis generically improves sleep for everyone? The evidence through 2014 simply didn't support it.

The Tolerance Trap

The review's implications extended well beyond a single night of use. For the millions of people using cannabis as a nightly sleep aid, the most concerning finding was about what happens over time.

This cycle is why Gates' review described the evidence as "mixed" rather than positive. The acute effects look promising. The chronic effects look like a trap. And most studies had been too short or too small to capture the full arc from benefit to dependence. Understanding this cycle is central to our guides on using cannabis to sleep every night, sleep recovery after quitting, and why withdrawal insomnia happens.

Why This Matters More Than It Seems

A systematic review that concludes "the evidence is inconclusive" might sound like a non-result. It isn't. In 2014, the cannabis sleep aid market was already worth hundreds of millions of dollars, built on a foundation of user testimonials and a handful of cherry-picked studies. Gates' review showed that the actual controlled evidence base — the studies where someone was given a cannabinoid and their sleep was measured — was small, fragmented, and contradictory.

The review also exposed the methodological chasm between what was needed and what existed. Cannabis is extraordinarily difficult to study in controlled settings. The drug is psychoactive, making blinding nearly impossible (participants know when they're high). Products are heterogeneous — a joint of sativa and a THC edible and nabilone are radically different interventions being lumped under "cannabinoids." Sleep outcomes are measured differently across studies — some used polysomnography, some used wrist actigraphy, some used questionnaires, and these instruments often disagree. Sample sizes were small, study durations were short, and populations were mixed.

The honest conclusion — "we can't say whether this works" — was itself a public health message at a time when consumer confidence had outpaced evidence by an enormous margin.

What's Changed Since 2014

Gates' review set the baseline. In the twelve years since, the picture has sharpened somewhat but not resolved:

The same team published a follow-up review in 2016 focused specifically on cannabis withdrawal and sleep, finding that sleep disruption during withdrawal was consistent across 36 studies — the clearest finding in the entire literature. Babson, Sottile, and Morabito's 2017 review synthesized newer evidence and began to distinguish between cannabinoids more carefully, noting that THC and CBD appear to have different and potentially opposing effects on sleep. A 2020 systematic review by Suraev and colleagues expanded the scope to include preclinical evidence, reinforcing that the most consistent human finding remains faster sleep onset with THC — and that everything else is still unclear.

A 2025 meta-analysis in Sleep Medicine Reviews — published in the same journal as Gates' original review — examined polysomnographic evidence specifically and found that cannabis administration does not consistently alter sleep duration, latency, wake time, efficiency, or sleep staging. The disconnect between what people report and what instruments measure persists.

The fundamental lesson from Gates 2014 has only been reinforced: cannabis is a sleep disruptor masquerading as a sleep aid. It works acutely by brute-forcing sedation, but it degrades the quality of the sleep you actually get — and when you stop, the rebound makes everything worse before it gets better. The good news, covered in our sleep recovery timeline: natural sleep architecture typically normalizes within two to four weeks of cessation.

Key Takeaways

The effects of cannabinoid administration on sleep: a systematic review of human studies

Gates PJ, Albertella L, Copeland J () · Sleep Medicine Reviews

Frequently Asked Questions

Cite this study

Gates, Peter J.; Albertella, Lucy; Copeland, Jan. (2014). The effects of cannabinoid administration on sleep: a systematic review of human studies. Sleep Medicine Reviews, 18(6), 477-487. https://doi.org/10.1016/j.smrv.2014.02.005

Related Research

RTHC-00301ObservationalPreliminary Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-00171Randomized Controlled TrialModerate Evidence2004RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-00205Randomized Controlled TrialStrong Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/researchRTHC-00216Case ReportPreliminary Evidence2006RETHINKTHC RESEARCH DATABASErethinkthc.com/research